Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kentucky Select Fund is a Louisville, Kentucky-based angel investment fund that backs early-stage companies rather than operating as a drug developer or healthcare company. The fund was approved under the Kentucky Investment Fund Act and has described a strategy focused on seed and Series A investments, with interests spanning information technology, healthcare, life sciences, biotech, medical devices, and media. Kentucky Select Fund typically invests up to $500,000 at the fund level and up to $2,000,000 with syndication partners. It appears to function as an investor and manager of portfolio company stakes, not as an operator of an internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kentucky Select Fund.